Literature DB >> 25368430

MUC1-C Induces the LIN28B→LET-7→HMGA2 Axis to Regulate Self-Renewal in NSCLC.

Maroof Alam1, Rehan Ahmad1, Hasan Rajabi1, Donald Kufe2.   

Abstract

UNLABELLED: The LIN28B→let-7 pathway contributes to regulation of the epithelial-mesenchymal transition (EMT) and stem cell self-renewal. The oncogenic MUC1-C transmembrane protein is aberrantly overexpressed in lung and other carcinomas; however, there is no known association between MUC1-C and the LIN28B→let-7 pathway. Here in non-small cell lung cancer (NSCLC), silencing MUC1-C downregulates the RNA-binding protein LIN28B and coordinately increases the miRNA let-7. Targeting MUC1-C function with a dominant-negative mutant or a peptide inhibitor provided confirming evidence that MUC1-C induces LIN28B→let-7 signaling. Mechanistically, MUC1-C promotes NF-κB p65 chromatin occupancy of the LIN28B first intron and activates LIN28B transcription, which is associated with suppression of let-7. Consistent with let-7-mediated inhibition of HMGA2 transcripts, targeting of MUC1-C also decreases HMGA2 expression. HMGA2 has been linked to stemness, and functions as a competing endogenous RNA (ceRNA) of let-7-mediated regulation of the TGFβ coreceptor TGFBR3. Accordingly, targeting MUC1-C suppresses HMGA2 mRNA and protein, which is associated with decreases in TGFBR3, reversal of the EMT phenotype, and inhibition of self-renewal capacity. These findings support a model in which MUC1-C activates the ⇑LIN28B→⇓let-7→⇑HMGA2 axis in NSCLC and thereby promotes EMT traits and stemness. IMPLICATIONS: A novel pathway is defined in which MUC1-C drives LIN28B→let-7→HMGA2 signaling, EMT, and self-renewal in NSCLC. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25368430      PMCID: PMC4369171          DOI: 10.1158/1541-7786.MCR-14-0363

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  52 in total

Review 1.  The epigenetics of epithelial-mesenchymal plasticity in cancer.

Authors:  Wai Leong Tam; Robert A Weinberg
Journal:  Nat Med       Date:  2013-11-07       Impact factor: 53.440

2.  MUC1 drives epithelial-mesenchymal transition in renal carcinoma through Wnt/β-catenin pathway and interaction with SNAIL promoter.

Authors:  Viviane Gnemmi; Audrey Bouillez; Kelly Gaudelot; Brigitte Hémon; Bélinda Ringot; Nicolas Pottier; François Glowacki; Arnauld Villers; David Vindrieux; Christelle Cauffiez; Isabelle Van Seuningen; David Bernard; Xavier Leroy; Sébastien Aubert; Michaël Perrais
Journal:  Cancer Lett       Date:  2013-12-30       Impact factor: 8.679

3.  Overexpression of HMGA2 promotes metastasis and impacts survival of colorectal cancers.

Authors:  Xiaochen Wang; Xiyong Liu; Angela Ying-Jian Li; Lirong Chen; Lily Lai; Her Helen Lin; Shuya Hu; Lifang Yao; Jiaping Peng; Sofia Loera; Lijun Xue; Bingsen Zhou; Lun Zhou; Shu Zheng; Peiguo Chu; Suzhan Zhang; David Kong Ann; Yun Yen
Journal:  Clin Cancer Res       Date:  2011-01-20       Impact factor: 12.531

4.  MUC1-C oncoprotein activates ERK→C/EBPβ signaling and induction of aldehyde dehydrogenase 1A1 in breast cancer cells.

Authors:  Maroof Alam; Rehan Ahmad; Hasan Rajabi; Akriti Kharbanda; Donald Kufe
Journal:  J Biol Chem       Date:  2013-09-16       Impact factor: 5.157

5.  Oncogenic MUC1-C promotes tamoxifen resistance in human breast cancer.

Authors:  Akriti Kharbanda; Hasan Rajabi; Caining Jin; Deepak Raina; Donald Kufe
Journal:  Mol Cancer Res       Date:  2013-03-28       Impact factor: 5.852

6.  The Lin28b-let-7-Hmga2 axis determines the higher self-renewal potential of fetal haematopoietic stem cells.

Authors:  Michael R Copley; Sonja Babovic; Claudia Benz; David J H F Knapp; Philip A Beer; David G Kent; Stefan Wohrer; David Q Treloar; Christopher Day; Keegan Rowe; Heidi Mader; Florian Kuchenbauer; R Keith Humphries; Connie J Eaves
Journal:  Nat Cell Biol       Date:  2013-06-30       Impact factor: 28.824

Review 7.  Lin28: primal regulator of growth and metabolism in stem cells.

Authors:  Ng Shyh-Chang; George Q Daley
Journal:  Cell Stem Cell       Date:  2013-04-04       Impact factor: 24.633

8.  LIN28B promotes growth and tumorigenesis of the intestinal epithelium via Let-7.

Authors:  Blair B Madison; Qi Liu; Xue Zhong; Christopher M Hahn; Nan Lin; Matthew J Emmett; Ben Z Stanger; Ju-Seog Lee; Anil K Rustgi
Journal:  Genes Dev       Date:  2013-10-15       Impact factor: 11.361

9.  HMGA2 functions as a competing endogenous RNA to promote lung cancer progression.

Authors:  Madhu S Kumar; Elena Armenteros-Monterroso; Philip East; Probir Chakravorty; Nik Matthews; Monte M Winslow; Julian Downward
Journal:  Nature       Date:  2013-12-04       Impact factor: 49.962

10.  Lin28B is an oncofetal circulating cancer stem cell-like marker associated with recurrence of hepatocellular carcinoma.

Authors:  Shu-Wen Cheng; Hung-Wen Tsai; Yih-Jyh Lin; Pin-Nan Cheng; Yu-Chung Chang; Chia-Jui Yen; Hsuan-Pang Huang; Yun-Pei Chuang; Ting-Tsung Chang; Chung-Ta Lee; Anning Chao; Cheng-Yang Chou; Shih-Huang Chan; Nan-Haw Chow; Chung-Liang Ho
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

View more
  34 in total

1.  MUC1-C drives MYC in multiple myeloma.

Authors:  Ashujit Tagde; Hasan Rajabi; Audrey Bouillez; Maroof Alam; Reddy Gali; Shannon Bailey; Yu-Tzu Tai; Teru Hideshima; Kenneth Anderson; David Avigan; Donald Kufe
Journal:  Blood       Date:  2016-02-23       Impact factor: 22.113

Review 2.  MUC1-C in chronic inflammation and carcinogenesis; emergence as a target for cancer treatment.

Authors:  Donald W Kufe
Journal:  Carcinogenesis       Date:  2020-09-24       Impact factor: 4.944

3.  HMGA2 regulates CD44 expression to promote gastric cancer cell motility and sphere formation.

Authors:  Junying Sun; Baocun Sun; Dongwang Zhu; Xiulan Zhao; Yanhui Zhang; Xueyi Dong; Na Che; Jing Li; Fang Liu; Nan Zhao; Danfang Zhang; Tieju Liu; Xian Lin
Journal:  Am J Cancer Res       Date:  2017-02-01       Impact factor: 6.166

4.  LIN28B enhanced tumorigenesis in an autochthonous KRASG12V-driven lung carcinoma mouse model.

Authors:  Lydia Meder; Katharina König; Felix Dietlein; Iris Macheleidt; Alexandra Florin; Meryem S Ercanoglu; Ursula Rommerscheidt-Fuss; Mirjam Koker; Gisela Schön; Margarete Odenthal; Florian Klein; Reinhard Büttner; Johannes H Schulte; Lukas C Heukamp; Roland T Ullrich
Journal:  Oncogene       Date:  2018-03-05       Impact factor: 9.867

5.  MUC1-C Activates the NuRD Complex to Drive Dedifferentiation of Triple-Negative Breast Cancer Cells.

Authors:  Tsuyoshi Hata; Hasan Rajabi; Hidekazu Takahashi; Yota Yasumizu; Wei Li; Caining Jin; Mark D Long; Qiang Hu; Song Liu; Atsushi Fushimi; Nami Yamashita; Ling Kui; Deli Hong; Masaaki Yamamoto; Masaaki Miyo; Masayuki Hiraki; Takahiro Maeda; Yozo Suzuki; Mehmet K Samur; Donald Kufe
Journal:  Cancer Res       Date:  2019-09-13       Impact factor: 12.701

6.  MicroRNA-4458 suppresses the proliferation of human lung cancer cells in vitro by directly targeting Lin28B.

Authors:  Chang-Hong Liu; De-Sheng Lv; Mo Li; Ge Sun; Xue-Fei Zhang; Yu Bai
Journal:  Acta Pharmacol Sin       Date:  2017-06-12       Impact factor: 6.150

Review 7.  MUC1-C Oncoprotein Integrates a Program of EMT, Epigenetic Reprogramming and Immune Evasion in Human Carcinomas.

Authors:  Hasan Rajabi; Donald Kufe
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-03-14       Impact factor: 10.680

8.  Melanoma cell-derived exosomes promote epithelial-mesenchymal transition in primary melanocytes through paracrine/autocrine signaling in the tumor microenvironment.

Authors:  Deyi Xiao; Samantha Barry; Daniel Kmetz; Michael Egger; Jianmin Pan; Shesh N Rai; Jifu Qu; Kelly M McMasters; Hongying Hao
Journal:  Cancer Lett       Date:  2016-04-07       Impact factor: 8.679

9.  Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemia.

Authors:  Jianbiao Zhou; Chonglei Bi; Ying Qing Ching; Jing-Yuan Chooi; Xiao Lu; Jessie Yiying Quah; Sabrina Hui-Min Toh; Zit-Liang Chan; Tuan Zea Tan; Phyllis Sy Chong; Wee-Joo Chng
Journal:  J Hematol Oncol       Date:  2017-07-11       Impact factor: 17.388

Review 10.  let-7 microRNAs: Their Role in Cerebral and Cardiovascular Diseases, Inflammation, Cancer, and Their Regulation.

Authors:  David L Bernstein; Xinpei Jiang; Slava Rom
Journal:  Biomedicines       Date:  2021-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.